|
|
Upcoming
Events | Related News
| Upcoming Events |
|
You may find that the following meetings will have presentations
of interest to you. International congresses and meetings where
you will find papers, abstracts and posters relating to new and
exciting technologies.
This listing of meetings is provided as an educational
service to the medical community. Bioheart, Inc. has no control
over the content/type of information presented at these meetings.
Dates are subject to change by the conference organizers.
|
Meeting |
Location |
Dates |
|
|
The
CCIB - Forum Convention Centre
Rambla Prim, 1-17
08109 Barcelona, Spain
|
May
13 - 16, 2008
|
Heart
Failure 2008
The
Heart Failure Congress, the annual meeting of the Heart
Failure Association of the ESC, is dedicated to all professionals
interested in the broad spectrum of problems relating to
heart failure. |
Congress
Centre
Milano
Convention Centre
Via Gattamelata 5
Milan, Italy
Tel:
+39 02 4997.7134
Fax: +39 02 4801.0265
|
June
14-17, 2008 |
14th World Congress on Heart Disease
International Academy
of Cardiology
Annual Scientific Sessions 2008 |
The Fairmont Royal York
100 Front Street West
Toronto, Ontario, Canada |
July 26-29, 2008 |
|
Metro
Toronto Convention Centre
Toronto, Ontario, Canada |
September
21-24, 2008 |
TCT
2008
|
Washington
Convention Center · Washington, DC
|
October
12-17, 2008
|
Scientific
Sessions 2008
[American Heart Association]
|
Ernest
N. Morial Convention Center
900 Convention Center Blvd.
New Orleans, LA
|
November
8-12, 2008
|
Cell
Therapy for Cardiovascular Disease
|
Tysons
Corner Ritz Carlton
Washington,
DC
|
November
20-21, 2008
|
| |
|
TOP
|
| Related News |
| May,
2008 |
Cell
Therapy in the Cath Lab for Heart Failure: A look at
MyoCell® Therapy and the SEISMIC Trial
Cath
Lab Digest talks with Warren Sherman, MD, Director, Cardiac
Cell-based Endovascular Therapies, Columbia University
Medical Center, New York, New York and Principal Investigator
of the Phase II/III MARVEL Study.
View
this Article...  [Requires
Adobe Acrobat Browser Plugin]
|
| |
|
| |
|
| April
1, 2008 |
Final
Data From the Bioheart Seismic Trial Suggest Safety,
Efficacy of Autologous Stem-Cell Therapy for Treating
Congestive Heart Failure
View
Press Release... [Requires
Adobe Acrobat Browser Plugin]
|
| |
|
| February
21, 2008 |
New
Victories for Adult Stem Cell Research
The
Adult Stem Cell Research Network announced that new clinical
and pre-clinical data on adult stem cells was presented at
the 4th Annual Meeting of Cell Therapy for Cardiovascular
Disease Sponsored by the Cardiovascular Research Foundation.
Dr. Warren Sherman of Columbia University presented final
one year results of the MYOHEART trial sponsored
by Bioheart, Inc., in which 83 percent of patients treated in this manner
with adult muscle stem cells, also known as myoblasts, improved.
View
Press Release... [Requires
Adobe Acrobat Browser Plugin]
|
| |
|
| February
2,
2008 |
Bioheart
New Joint Venture Facility In Asia
On
September 11, 2007, BioHeart Manufacturing (BHM) inaugurated
its cGMP certified cell culture facility in Seoul, South
Korea. This is South Korea’s first such facility. Built at
an investment of $22 million the BHM facility is a joint
venture
between
Seoul-headquartered BHK Inc and US-based BioHeart Inc. Bioheart
has the capacity to culture 46,000 cases annually in
this building.
View
Facility Photo's [Requires
Adobe Acrobat Browser Plugin]
|
| |
|
| November
21,
2007 |
Regulatory
Panel at Angiomyogenesis Symposium at CRT 2008
Regulatory
Panel Session will take place on Tuesday
evening of the Symposium on February 12, 2008.
View
Event Brochure | Register
Online [Requires
Adobe Acrobat Browser Plugin]
|
| |
|
| March
7, 2007 |
Bioheart,
Inc. Appoints William H. Pinon President and CEO
Cardiovascular
Industry Veteran Brings Nearly 20 Years of Experience to
Bioheart
View
Press Release
|
| |
|
| February
26, 2007 |
Bioheart,
Inc. Provides Unrestricted Research Grant to the Ohio
Cell-Based Therapy Consortium
View
Press Release
|
| |
|
| January,
2007 |
Myocardial
Repair By Percutaneous Cell Transplantation Of Autologous
Skeletal Myoblasts As A Stand Alone Procedure In Post
Myocardial Infarction Chronic Heart Failure Patients.
Patrick
W. Serruys, MD, PhD on behalf of the BIOHEART European
005/006 and 008 study investigators. (3rd Annual Conference
on Cell Therapy for Cardiovascular Diseases, New York,
January, 2007)
View
This Info... [Requires
Adobe Acrobat Browser Plugin]
MYOHEART
US Phase I Study - Interim Analysis - January 2007
Download
Microsoft PowerPoint SlideShow
(32kb - RIGHT CLICK
AND "SAVE TO HARD DRIVE" - Requires: PowerPoint
Viewer for Windows | PowerPoint
Viewer for MAC)
|
| |
|
| January
17, 2007 |
Dr.
Jorge Genovese Joins Bioheart, Inc. Scientific Advisory
Board
View
Press Release
|
| |
|
| December
27, 2006 |
Tissue
Genesis Licenses Technology to Florida Company
View
Press Release
|
| |
|
| November
17, 2006 |
Bioheart,
Inc. Expands Clinical Trials Of Adult Myogenic Stem Cell
Treatment For Heart Attack And Advanced Heart Failure
Patients
Bioheart, Inc., a biotechnology
company focused on the development of innovative cell therapies
designed to repair areas of damaged muscle tissue in a
patient's heart and improve cardiac function, is expanding
its United States and European clinical trials of its MyoCell(TM)
adult myogenic (muscle) stem cell composition and MyoCath(R)
needle-injection catheter product candidates. MyoCell(TM)
is a non-acute, clinical therapy for treatment of damage
to the heart in patients in Class II or Class III heart
failure. Bioheart believes that its MyoCell(TM) therapy
has the potential to become a leading non-acute treatment
for severe damage to the heart due to its perceived ability
to satisfy a presently unmet demand for more effective
and/or more affordable non-acute therapies for heart damage. Read
the Article
|
| |
|
| November
15, 2006 |
Cell
Transfer for Heart Patient
A
man who has had six heart attacks is one of the first
UK patients to undergo an experimental cell transfer. Read
the Full Story... | View
BBC News Video
|
| |
|
| November
8 , 2006 |
Ascent
Closes First Deal of $100M Medical Technology Fund.
Recently,
Ascent has become the lead investor in a private placement
for cutting-edge cardiovascular technology startup, Bioheart,
a US based company that is conducting clinical studies
in the US and Europe for regulatory approval prior to
marketing globally. Bioheart's
technology aims to change the way congestive heart failure
is treated by using a new method of cell engineering.
Bioheart will establish a cell engineering and production
facility in the Middle East. Read
the Full Article...
|
| |
|
| August
8 , 2006 |
Bioheart
Acquires Exclusive Option Rights to Tissue Genesis' Cell
Technology for the Acute Treatment of Heart Attacks.
Read
this Article
|
| |
|
| July
31, 2006 |
U
of M Uses Robotic Surgery Techniques in Cell Therapy
Research for Cardiac Repair.
Read
this Article
|
| |
|
| June
26, 2006 |
Bioheart,
Inc. to Receive Funds From a Grant Awarded by the State
of Ohio to Further Develop Adult Stem Cell Therapies.
Read
this Article
|
| |
|
| May
19, 2006 |
Tricardia
Inks Licensing Deal With Bioheart.
Read
this Article
|
| |
|
| June
2, 2006 |
Bioheart
and PharmaCell Open GMP Lab Facility in Europe to Support
Adult Stem Cell Research.
View
Press Release
|
| |
|
| April
27, 2006 |
Bioheart,
Inc and Tricardia, LLC Sign Patent Licensing Agreement.
View
Press Release
|
| |
|
| March
2006 |
Intramyocardial
Injection Of Skeletal Myoblasts: Long-Term Follow-up with
Pressure-Volume Loops. Steendijk P, Smits PC, Valgimigli
M, van der Giessen WJ, Onderwater EE, Serruys PW. View
an Abstract of this Article | View
the Full Article |
| |
|
| March
24, 2006 |
Licensing
Deal, Funding Boost Bioheart.
View
PDF Article [100k
- [Requires
Adobe Acrobat Browser Plugin]
|
| |
|
| |
Bioheart
Hires Jason Sholder to Lead a Project of Developing an
Implantable Electrical Stimulation Device to Complement
Its Cell Transplantation Product Platform.
View
Press Release
|
| |
|
| February
20, 2006 |
Bioheart
Licenses Cell Patent.
Read
this Article
|
| |
|
| February
20, 2006 |
Bioheart,
Inc. and Cleveland Clinic Sign Major Patent Licensing
Agreement.
Read
this Article
|
| |
|
| February
20, 2006 |
Bioheart
Licenses Cell Patent - Deal With Cleveland Clinic
Focuses On Repairing Heart Tissue.
Read
this Article
|
TOP
|
|
Web
site by Bromley Printing and Design